Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer
- PMID: 15643496
Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer
Abstract
The aim of this study was to define the frequency and clinical relevance of cytokeratin positive metastatic tumor cells in the peripheral circulation of patients with stage IV breast cancer. Peripheral blood was collected from 32 consecutive patients with metastatic breast cancer and 23 healthy donors. Tumor cells were enriched using positive selection with anti-HEA125-microbeads and cytospins were prepared of the positive selection eluate. Slides were incubated with a Fab2 fragment of the pancytokeratin antibody A45-B/B3 conjugated with alkaline phosphatase (AKP) and a CAM5.2-AKP monoclonal antibody and developed with an alkaline phosphatase anti-alkaline phosphate reaction (APAAP). All samples were evaluated using light microscopy and an automated image analysis system. In 8/32 (25%) patients cytokeratin positive (CK+) cells could be detected after anti-HEA125 enrichment in the peripheral blood whereas in none out of 23 healthy donors. One to 1000 (median 5) positive cells per patient sample were observed and cluster of tumor cells in one patient. Automated image analysis was as powerful in detecting micrometastases as conventional light microscopy. All patients with CK+ cells in the peripheral circulation (8/8, 100%) showed progressive disease at the time-point of blood draw whilst only 9/24 (37.5%) showed disease progression without detection of positive cells. The median overall survival of CK+ patients was 4+/-2 months compared to 13+/-7 months of CK- patients (p<0.001). CK+ cells are detectable in the peripheral circulation of 25% of patients with metastatic breast cancer after positive selection with anti-HEA125. Detection of tumor cells in the peripheral circulation might be correlated with progression of disease and shorter overall survival.
Similar articles
-
Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.Clin Cancer Res. 2002 May;8(5):1085-91. Clin Cancer Res. 2002. PMID: 12006523
-
Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.Anticancer Res. 2003 Mar-Apr;23(2C):1883-90. Anticancer Res. 2003. PMID: 12820473
-
Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.Clin Cancer Res. 2005 May 15;11(10):3678-85. doi: 10.1158/1078-0432.CCR-04-2469. Clin Cancer Res. 2005. PMID: 15897564
-
Circulating tumor cells as prognostic marker in metastatic breast cancer.Expert Rev Anticancer Ther. 2010 Feb;10(2):171-7. doi: 10.1586/era.09.105. Expert Rev Anticancer Ther. 2010. PMID: 20131993 Review.
-
[Circulating DNA, telomerase of circulating tumor cells and early diagnosis of tumors].Ai Zheng. 2004 Feb;23(2):227-9. Ai Zheng. 2004. PMID: 14960252 Review. Chinese.
Cited by
-
Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications.Theranostics. 2020 Oct 26;10(26):12060-12071. doi: 10.7150/thno.48918. eCollection 2020. Theranostics. 2020. PMID: 33204329 Free PMC article. Review.
-
Metastatic dissemination patterns of different primary tumors to the spine and other bones.Clin Exp Metastasis. 2019 Dec;36(6):493-498. doi: 10.1007/s10585-019-09987-w. Epub 2019 Aug 16. Clin Exp Metastasis. 2019. PMID: 31420767
-
Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.J Mol Diagn. 2005 Nov;7(5):631-7. doi: 10.1016/S1525-1578(10)60597-1. J Mol Diagn. 2005. PMID: 16258162 Free PMC article.
-
Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.J Patient Cent Res Rev. 2014 Spring;1(2):85-92. doi: 10.17294/2330-0698.1017. J Patient Cent Res Rev. 2014. PMID: 25914894 Free PMC article.
-
Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.J Clin Immunol. 2008 Mar;28(2):107-14. doi: 10.1007/s10875-007-9139-2. Epub 2007 Oct 16. J Clin Immunol. 2008. PMID: 17939021
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials